Biogen News and Research

RSS

National Multiple Sclerosis Society awards grant for pilot study of social interaction in individuals with MS

Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.

26 Feb 2019

Unique data combination helps FinnGen researchers to fund links between genetic factors and health

The FinnGen study, launched in autumn 2017, is a broad academic-industrial collaboration between the Finnish biobanks and their respective Universities, University Hospitals, the Institute of Health and Welfare, the Finnish Red Cross Blood Service and now nine international pharmaceutical companies

23 Jan 2019

Genetic testing can help personalize diagnosis and treatment of kidney disease, study shows

A new study has found that genes cause about 1 in 10 cases of chronic kidney disease in adults, and identifying the responsible gene has a direct impact on treatment for most of these patients.

26 Dec 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Neuropsychiatric symptoms related to earliest stages of Alzheimer's brain pathology

UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer's disease are linked to neuropsychiatric symptoms including anxiety, depression, loss of appetite, and sleep disturbances.

15 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Older individuals with multiple sclerosis report higher quality of life than younger counterparts

A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.

20 Sep 2018

Processing speed important to higher order cognitive function in multiple sclerosis patients

A recent article by Kessler Foundation researchers underscores the importance of processing speed in overall cognitive function in individuals with multiple sclerosis and their performance of everyday life activities.

19 Sep 2018

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

A new report has identified an alternative method to deliver nusinersen to patients with spinal muscular atrophy using a subcutaneous intrathecal catheter system configured by connecting an intrathecal catheter to an implantable infusion port.

24 Aug 2018

New study investigates whether nicotine could slow memory loss

Can nicotine slow or stop memory loss in people experiencing mild memory problems, or mild cognitive impairment? A new study being conducted at Georgetown University Medical Center aims to find out.

9 Aug 2018

Newer version of ALS drug may effectively treat inherited form of the disease

NIH-funded researchers delayed signs of amyotrophic lateral sclerosis in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1.

27 Jul 2018

Brain scan can help select the right Parkinson’s patients for clinical trials

From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson’s – a brain scan that can be used to select the right people for clinical trials.

27 Jul 2018

Qualification of first Parkinson's biomarker represents major milestone in clinical trials

The biomarker is used to determine the presence of dopamine transport deficiency in the brain, and has been qualified as an enrichment biomarker for clinical trials targeting early stages of Parkinson's, soon after diagnosis

27 Jul 2018

Scientists provide clear picture of mysterious component of the inner ear

A few years ago, Ian Swinburne, HMS research fellow in systems biology, noticed something odd while conducting a time-lapse microscopy study of the inner ear of zebrafish. A tiny structure in the inner ear was pulsing like clockwork, inflating and deflating over and over.

29 Jun 2018

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

20 Jun 2018

Research: Memory processes depend on protein ‘off-switch’ in the brain

Memory, learning and cognitive flexibility depend on a protein 'off-switch' in the brain, according to a breakthrough discovery made by an international research collaboration co-led by the University of Warwick.

1 Jun 2018

New microscope reveals how cells behave in 3D and real time inside living organisms

Astronomers developed a "guide star" adaptive optics technique to obtain the most crystal-clear and precise telescopic images of distant galaxies, stars and planets. Now a team of scientists, led by Nobel laureate Eric Betzig, PhD, are borrowing the very same trick.

20 Apr 2018

Biogen News and Research

National Multiple Sclerosis Society awards grant for pilot study of social interaction in individuals with MS

Unique data combination helps FinnGen researchers to fund links between genetic factors and health

Genetic testing can help personalize diagnosis and treatment of kidney disease, study shows

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Neuropsychiatric symptoms related to earliest stages of Alzheimer's brain pathology

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Older individuals with multiple sclerosis report higher quality of life than younger counterparts

Processing speed important to higher order cognitive function in multiple sclerosis patients

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

New study investigates whether nicotine could slow memory loss

Newer version of ALS drug may effectively treat inherited form of the disease

Brain scan can help select the right Parkinson’s patients for clinical trials

Qualification of first Parkinson's biomarker represents major milestone in clinical trials

Scientists provide clear picture of mysterious component of the inner ear

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

Research: Memory processes depend on protein ‘off-switch’ in the brain

New microscope reveals how cells behave in 3D and real time inside living organisms

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News